News Releases

XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca
NEW YORK, Oct. 10 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a family of 20 fund portfolios, today announced its Board of Directors has approved the transfer of its 19 currently NYSE-listed HealthShares exchange-traded funds (ETFs) to the NYSE Arca trading platform in accordance with NYSE Euronext requirement to transfer of all ETFs to the NYSE Arca LMM platform. The transfer is expected to be completed by October 26, 2007.

    The ETFs scheduled to migrate to NYSE Arca include:
    HealthShares Autoimmune-Inflammation ETF                               HHA
    HealthShares Cancer ETF                                                HHK
    HealthShares Cardio Devices ETF                                        HHE
    HealthShares Cardiology ETF                                            HRD
    HealthShares Composite ETF                                             HHQ
    HealthShares Dermatology & Wound Care ETF                              HRW
    HealthShares Diagnostics ETF                                           HHD
    HealthShares Emerging Cancer ETF                                       HHJ
    HealthShares Enabling Technologies ETF                                 HHV
    HealthShares European Drugs ETF                                        HRJ
    HealthShares European Medical Products & Devices ETF                   HHT
    HealthShares GI/Gender Health ETF                                      HHU
    HealthShares Infectious Disease ETF                                    HHG
    HealthShares Metabolic-Endocrine Disorders ETF                         HHM
    HealthShares Neuroscience ETF                                          HHN
    HealthShares Ophthalmology ETF                                         HHZ
    HealthShares Orthopedic Repair ETF                                     HHP
    HealthShares Patient Care Services ETF                                 HHB
    HealthShares Respiratory/Pulmonary ETF                                 HHR

About HealthShares(TM)
XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of 20 Exchange Traded Funds (ETFs), of which 19 are currently trading. HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.).

Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at .

About XShares
XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registered investment advisor that provides investment advisory services to Exchange Traded Funds. XShares also partners with major institutions and index providers seeking to bring innovative Exchange Traded Funds to market using its administrative platform. In addition, XShares creates and licenses distinctive intellectual property for its ETFs, developing products that allow for innovative trading strategies and alternative investments for the financial community. For more information, visit the website at .

An Investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. For this and more complete information about the fund call 800.925.2870 or visit the website for a prospectus. Please read the prospectus carefully before investing.

There are risks involved with investing in ETFs including possible loss of money. HealthShares(TM) are not actively managed and are subject to risks similar to stocks, including those related to short selling and margin maintenance. Losses from short sales may be unlimited, and losses from purchases on margin may exceed original investment. HealthShares(TM) ETFs are subject to increased risks associated with investing in a specific sector compared to a more diversified investment, as well as unique risks associated with the healthcare and biotechnology sector (i.e., government regulation, patent regulation, etc.). The ETFs face additional risks attributable to their investments in small and medium capitalization companies which are subject to higher volatility than larger, more established companies. In addition, they are invested in a limited number of securities and a decline in the value of these investments would cause the fund's overall value to decline to a greater degree than in a less concentrated portfolio. Global or International Funds invest in foreign securities that will be subject to certain risks not associated with domestic securities, such as currency fluctuations, and changes in political and economic conditions. The prospectus is not an offer to buy or sell the portfolio shares, nor is the fund soliciting an offer to buy its shares in any jurisdiction where the offer or sale is not permitted.

HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors, Inc. XShares Advisors LLC and ALPS Distributors, Inc. are unaffiliated

    Contact Information
    For XShares:
    Melissa Kanter

Contact: Eric Ryan
Phone: 212.656.2411